BioCryst Pharmaceuticals ...

8.39
0.17 (2.07%)
At close: Apr 25, 2025, 3:59 PM
8.40
0.06%
After-hours: Apr 25, 2025, 05:49 PM EDT

BioCryst Pharmaceuticals Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for BCRX stock have an median target of 13.5, with a low estimate of 8 and a high estimate of 18. The median target predicts an increase of 60.91% from the current stock price of 8.39.

Target Low Average Median High
Price $8 $13.67 $13.5 $18
Change -4.65% 62.93% 60.91% 114.54%

Latest Analyst Insight Report

RBC Capital maintains an Outperform rating for Bio... Unlock content with Pro Subscription

Updated Apr 11, 2025

Rating Nov 24Dec 24Jan 25Feb 25Mar 25Apr 25
Strong Buy 011000
Buy 202312
Hold 100000
Sell 000000
Strong Sell 000000
Total 3 1 3 3 1 2

Financial Forecast this Year

Revenue This Year
563.66M
from 450.71M
Increased by 25.1%
Revenue Next Year
646.2M
from 563.66M
Increased by 14.6%
EPS This Year
-0.07
from -0.43
Increased by 83.7%
EPS Next Year
0.23
from -0.07
Increased by -228.6%